Skip to content
Get alerts
GovInfoNow
Lower risk Drug recall · FDA · Published February 3, 2020

Contract Pharmacal recalls acetaminophen tablets with foreign tablets risk

Contract Pharmacal recalls 100-count and 1000-count acetaminophen tablets due to foreign tablets found in one bottle. Consumers should check product labels for NDC numbers.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0858-2020DrugContract Pharmacal ›
Take action

Contact the company

Recalling firmContract Pharmacal Corporation135 Adams Ave · Hauppauge, NY 11788-3633
✎ GovInfoNow plain-language explainer

Contract Pharmacal is recalling 100-count and 1000-count bottles of 500mg acetaminophen tablets after one complaint found foreign tablets in a bottle. This could cause accidental ingestion of harmful substances if the foreign tablets are taken. Read more at govinfonow.com/recall/37384-contract-pharmacal-recalls-acetaminophen-tablets-with-foreign-tablets-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37384-contract-pharmacal-recalls-acetaminophen-tablets-with-foreign-tablets-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0858-2020

Cite this page

“Contract Pharmacal recalls acetaminophen tablets with foreign tablets risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37384-contract-pharmacal-recalls-acetaminophen-tablets-with-foreign-tablets-risk. Based on FDA recall #D-0858-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0858-2020%22&limit=1).

Contract Pharmacal Corporation recalled Major Extra Strength Acetaminophen Tablets, 500 mg, due to the presence of foreign tablets, according to the FDA. The Food and Drug Administration announced the recall on Feb. 3, 2020.

How to tell if you have it

  • Major Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer
  • 100-count bottles (NDC 0904-6730-60; UPC 3 09046 73060 6)
  • 1000-count bottles (NDC 0904-6730-80; UPC 3 09046 73080 4)
  • Lot #: 193005
  • Exp. Date 08/21

The hazard

The recall involves the presence of foreign tablets, specifically a Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents. The record reports one complaint involving this commingling.

Context

GovInfoNow's records show Contract Pharmacal Corporation has 1 other recall on record since 2024-05-20. On 2024-05-20, Major Pharma issued a recall for Acetaminophen due to discolored tablets. Other recent recalls of similar products include Golden State Baclofen Tablets Recall (2025-11-26), Bionpharma Divalproex Tablets Recall (2026-06-26), and Amerisource Health Primidone Tablets Recall (2026-05-01).

How to tell if you have this one

Check for 100-count bottles with NDC 0904-6730-60 or 1000-count bottles with NDC 0904-6730-80. The recall covers bottles distributed by Major Pharmaceuticals in the US.

  • Brand
    Contract Pharmacal
  • Product
    Major Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer, packaged in a) 100-count bottles (NDC
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide within the United States
Recall numberProduct, codes & lotsQuantityNDC
D-0857-2020Leader Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer,100-count bottles,Distributed by Cardinal Health, Dublin OHIO 43017 NDC 7000-0036-1, UPC 0 96295 13807 8; Lot #: 193005, Exp. Date 08/215472 bottles—
D-0858-2020Major Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer, packaged in a) 100-count bottles (NDC 0904-6730-60; UPC 3 09046 73060 6) and b) 1000-count bottles (NDC 0904-6730-80; UPC 3 09046 73080 4) Distributed by Major Pharmaceuticals 17177 N. Laurel Park Drive, Suite 233 Livonia, MI 45162 USA; Lot #: 193005, Exp. Date 08/21a) 1176 bottles b) 6,216 bottles0904-6730-60, 0904-6730-80, 0904-6730-59, 0904-6730-61
Based on the official FDA remedy

What to do — step by step

  1. Check Product Labels

    Look for NDC numbers 0904-6730-60 (100-count) or 0904-6730-80 (1000-count) on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 4.2 years after the firm started it.

1. Firm started the recall: Feb 3, 202012. Published in FDA’s Enforcement Report: Feb 19, 202023. FDA classified it Class II: Feb 27, 202034. FDA terminated the recall: Apr 22, 2024420202024
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class II
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

What should I do if I have the recalled product?

Check the product labels for NDC numbers 0904-6730-60 or 0904-6730-80. If you have the product, you should stop using it and contact the manufacturer.

Similar recalls

Golden State Baclofen Tablets Recall: Foreign Tablets Risk
Golden State Medical SupplyBionpharma Divalproex Tablets Recall: Foreign Tablets Risk
BionpharmaAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.

Latest drug recalls

SUN PHARMACEUTICAL INDUSTRIES INC recalls Tretinoin Cream USP, 0.05%, 45 g tube, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Taro
Northstar Rx · September 25, 2026Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0858-2020 (February 3, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0858-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA